NCT07117214

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2026-06-01Est. Completion: 2028-10-31

Enrollment target: 36 participants

Locations

Contact

Novartis Pharmaceuticals

Breast CancerAnthracycline Related Cardiotoxicity in Breast CancerVirtual RealityTrastuzumab

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experienc…

Richmond, United StatesEst. completion Jul 30, 2026

Early Breast Cancer

This is a Phase III, global, randomized, open-label, multicenter, study evaluating the efficacy and safety of adjuvant g…

Daphne, United StatesEst. completion Aug 8, 2025

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.